Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Biotest AG
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
Janssen Biotech adds to its bispecific antibody pipeline for cancer via pair of collaborations. Ipsen and Accent pair up to investigate new target for acute myeloid leukemia.
Appili brings in AiPharma to help with US/Canadian development of Fujifilm’s potential COVID-19 preventative/therapeutic. Other recent tie-ups include CinFina/Janssen, Bone/Impant, Bayer/Gubra, Novartis/Theragnostics, Grifols/Biotest and more.
Dozens of life science companies are working to find effective treatments for COVID-19. In addition to our daily in-depth coverage of key regulatory events relating to the coronavirus pandemic, we’re bringing you selected brief insights into some of the efforts that are under way on this front.
- Large Molecule
- Other Names / Subsidiaries
- Creat Group Corporation
- Grifols, S.A.
- Tiancheng (Germany) Pharmaceutical Holdings AG
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.